Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 28, 2019
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
[ Mon, Oct 28th 2019
] - WOPRAI
Fri, October 25, 2019
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
[ Fri, Oct 25th 2019
] - WOPRAI
Liana Moussatos Maintained (BMRN) at Buy with Increased Target to $152 on, Oct 25th, 2019
Liana Moussatos of Wedbush, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $128 to $152 on, Oct 25th, 2019.
Liana has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, all agrees with Liana's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $86 on, Thursday, October 24th, 2019
Similar Stocks and Investing Articles
[ Fri, Oct 26th 2018
] - WOPRAI
[ Wed, Oct 24th 2018
] - WOPRAI
[ Tue, Oct 23rd 2018
] - WOPRAI
[ Mon, Oct 01st 2018
] - WOPRAI
[ Thu, Aug 09th 2018
] - WOPRAI
[ Tue, Nov 29th 2016
] - WOPRAI
[ Tue, Nov 06th 2012
] - WOPRAI
[ Mon, Nov 05th 2012
] - WOPRAI
[ Thu, Sep 27th 2012
] - WOPRAI